Ling Ouyang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 4
-
- Cancer-related molecular mechanisms research 2
- MicroRNA in disease regulation 2
- Co-authors
- Bo Li (2 shared papers)Peng Chen (5 shared papers)Zixuan Song (10 shared papers)Kuiran Liu (4 shared papers)Yizi Wang (7 shared papers)Yan Li (3 shared papers)Fang Ren (5 shared papers)Cuishan Guo (3 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Frontiers in Endocrinology (4 papers)Oncotarget (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Nutrition (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ling Ouyang
34 papers receiving 663 citations
Ling Ouyang's Hit Papers
Peers
Comparison fields: 5 of 52
- Cancer Research 79
- Obstetrics and Gynecology 50
- Reproductive Medicine 48
- Oncology 42
- Molecular Biology 106
Countries citing papers authored by Ling Ouyang
This map shows the geographic impact of Ling Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ouyang more than expected).
Fields of papers citing papers by Ling Ouyang
This network shows the impact of papers produced by Ling Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ouyang. The network helps show where Ling Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of estrogen receptors in health and disease Hit paper breakdown → | 2022 | 189 |
| 2 | 2021 | 55 | |
| 3 | 2019 | 45 | |
| 4 | 2017 | 40 | |
| 5 | 2017 | 37 | |
| 6 | 2020 | 34 | |
| 7 | 2021 | 28 | |
| 8 | 2019 | 25 | |
| 9 | 2020 | 25 | |
| 10 | 2013 | 22 | |
| 11 | 2016 | 18 | |
| 12 | 2018 | 18 | |
| 13 | 2020 | 17 | |
| 14 | 2022 | 17 | |
| 15 | 2020 | 15 | |
| 16 | 2021 | 13 | |
| 17 | 2013 | 8 | |
| 18 | 2016 | 8 | |
| 19 | Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status. | 2015 | 7 |
| 20 | Aberrant staining patterns of E-cadherin and β-catenin: a potential diagnostic value for distinguishing vulvar intraepithelial neoplasia from non-neoplastic vulvar lesions. | 2013 | 6 |
About Ling Ouyang
Ling Ouyang is a scholar working on Reproductive Medicine, Cancer Research, Obstetrics and Gynecology, Rheumatology and Oncology, having authored 38 papers that have together received 673 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Cancer-related molecular mechanisms research (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), MicroRNA in disease regulation (2 papers), Ubiquitin and proteasome pathways (2 papers), Cervical Cancer and HPV Research (1 paper), Folate and B Vitamins Research (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (79 citations), Obstetrics and Gynecology (50 citations), Reproductive Medicine (48 citations), Oncology (42 citations) and Molecular Biology (106 citations). Ling Ouyang has collaborated with scholars based in China and United States. Frequent co-authors include Bo Li, Peng Chen, Zixuan Song, Kuiran Liu, Yizi Wang, Yan Li, Fang Ren, Cuishan Guo, Qi Dong Zhao and Xiaoying Wang. Their work appears in journals such as Frontiers in Oncology, Frontiers in Endocrinology, Oncotarget, Frontiers in Pharmacology and Frontiers in Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.